Avacta Group Plc is a clinical stage biopharmaceutical company, which engages in the development of precision oncology therapies. Its proprietary technology platforms include pre|CISION and Affimer. The company was founded by Alastair MacLaughlin Smith, Simon Webster, and Kurt Justin Baldwin on April 29, 2003 and is headquartered in London, the United Kingdom.